文献速递结核与非结核分枝杆菌细菌感染、耐药与抗菌药物

三噬菌体组合在疾病相关条件下抗结核分枝杆菌的活性

Activity of a three-phage combination against Mycobacterium tuberculosis in disease-relevant conditions.
PubMed 文献 · J Infect Dis · 2026-10-15

本研究评估三噬菌体组合在缺氧、酸性(pH 5.5)及稳定期条件下对结核分枝杆菌H37Rv的体外活性。结果显示,在活跃生长菌中噬菌体水平第7天上升并持续降低菌量达31天,且阻止了单用抗生素后的再生长;但在缺氧和稳定期非复制状态下未见杀菌活性。

要点

  • 噬菌体组合对活跃生长结核分枝杆菌有持续杀菌活性并抑制再生长
  • 缺氧和稳定期非复制菌中噬菌体滴度稳定但无细菌减少
  • 酸性条件对单个噬菌体稳定性和活性的影响不一

核心结论

  • 在非复制结核分枝杆菌中未观察到有效的裂解活性,但模型可支持未来实验设计并为噬菌体疗法开发提供机制见解。

研究设计与样本

  • 体外研究,使用结核分枝杆菌H37Rv培养物,在正常、缺氧和酸性条件下进行时间-杀菌研究,并采用纵向噬菌体-细菌动力学混合效应模型模拟。

主要发现

  • 在活跃生长培养中,噬菌体水平第7天上升,随后31天内结核分枝杆菌计数持续降低。
  • 噬菌体阻止了单用抗生素(利福平或异烟肼0.1 µg/mL)时观察到的再生长。
  • 酸性条件对单个噬菌体的稳定性和活性有不同影响。
  • 在缺氧和稳定期条件下,噬菌体滴度保持稳定,但未观察到结核分枝杆菌减少。
  • 基于模型的预测充分捕捉了有无利福平情况下的噬菌体-分枝杆菌相互作用。

关键数值与推荐

  • 时间-杀菌研究中结核分枝杆菌H37Rv浓度为10^6 CFU/mL。
  • 噬菌体组合感染复数(MOI)为10:1。
  • 利福平和异烟肼浓度均为0.1 µg/mL。
  • 酸性条件pH为5.5。
  • 稳定期培养物生长14-21天后未稀释使用。

临床怎么用

  • 对于活跃生长的结核分枝杆菌,三噬菌体组合可能具有抑制再生长潜力,但需进一步临床验证。
  • 在缺氧或稳定期非复制状态下,该噬菌体组合未见杀菌效果,临床应用需考虑微环境状态。

局限性

  • 研究为体外实验,结果不能直接外推至体内或临床。
  • 未在动物模型或人体中验证噬菌体组合的疗效与安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Phage therapy offers promise to combat antimicrobial resistance, including drug-resistant tuberculosis. Understanding phage activity against Mycobacterium tuberculosis (Mtb) in granuloma-like microenvironments that induce non-replicating states, characterized by hypoxia and acidity, is essential. OBJECTIVES: To evaluate a phage combination against Mtb under hypoxic, acidic (pH 5.5), and stationary-phase conditions in vitro. METHODS: Mtb H37Rv cultures were grown to exponential phase for time-kill studies (106 colony forming units (CFU)/mL) under normal, hypoxic, and acidic conditions. Hypoxia was generated using sealed containers with gas sachets. Stationary-phase cultures were grown for 14-21 days and used undiluted. Treatments included control media, single phages (Fred313cpm-1Δ33, FionnbharthΔ45Δ47and Muddy HRM N0157-2), phage combination (multiplicity of infection 10:1), and rifampicin or isoniazid (0.1 µg/mL each). Phage titers (measured using M. smegmatis overlays) and bacterial counts (CFU on Middlebrook 7H11) were assessed at repeated time-points. Longitudinal phage-bacteria dynamics mixed-effects modelling and simulation was performed. RESULTS: In actively growing cultures, phage levels rose by day 7, followed by sustained reductions in Mtb counts over 31 days. Phages prevented regrowth seen with antibiotics alone. Acidic conditions variably affected individual phage stability and activity. Under hypoxic and stationary conditions, phage titers remained stable, but no reduction in Mtb was observed. Model-based predictions adequately captured phage-mycobacterial interactions with and without rifampicin. CONCLUSIONS: Productive lytic activity was not observed in assays with non-replicating mycobacteria. Established models can support future experimental designs. This study provides mechanistic insights driving progress in the field of phage therapy development.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Janssen S, Larsen SE, Torres MP, et al. Activity of a three-phage combination against Mycobacterium tuberculosis in disease-relevant conditions. J Infect Dis. 2026. PMID: 42879186. doi:10.1093/infdis/jiag516

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。